When patients have more severe T2D, for example, high insulin resistance, or combined with fatty liver disease, we suggest combining GLP-1 with DMR, because of the apparent positive effects on glycemia and metabolic health of this combination. This evidence concerns the gene GLP1R and fatty liver disease.